Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP629494.RAR5MephDzFdREmadrxepryA-mOWFAKv66qzwT3M5ic9Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP629494.RAR5MephDzFdREmadrxepryA-mOWFAKv66qzwT3M5ic9Y130_assertion type Assertion NP629494.RAR5MephDzFdREmadrxepryA-mOWFAKv66qzwT3M5ic9Y130_head.
- NP629494.RAR5MephDzFdREmadrxepryA-mOWFAKv66qzwT3M5ic9Y130_assertion wasGeneratedBy ECO_0000203 NP629494.RAR5MephDzFdREmadrxepryA-mOWFAKv66qzwT3M5ic9Y130_provenance.
- NP629494.RAR5MephDzFdREmadrxepryA-mOWFAKv66qzwT3M5ic9Y130_assertion wasDerivedFrom befree-20150227 NP629494.RAR5MephDzFdREmadrxepryA-mOWFAKv66qzwT3M5ic9Y130_provenance.
- NP629494.RAR5MephDzFdREmadrxepryA-mOWFAKv66qzwT3M5ic9Y130_assertion SIO_000772 16008557 NP629494.RAR5MephDzFdREmadrxepryA-mOWFAKv66qzwT3M5ic9Y130_provenance.
- NP629494.RAR5MephDzFdREmadrxepryA-mOWFAKv66qzwT3M5ic9Y130_assertion evidence source_evidence_literature NP629494.RAR5MephDzFdREmadrxepryA-mOWFAKv66qzwT3M5ic9Y130_provenance.
- NP629494.RAR5MephDzFdREmadrxepryA-mOWFAKv66qzwT3M5ic9Y130_assertion description "[The use of DNAzyme methodology adds a new potential clinical agent for decreasing uPAR mRNA expression and inhibiting cancer invasion and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP629494.RAR5MephDzFdREmadrxepryA-mOWFAKv66qzwT3M5ic9Y130_provenance.